Skip to content

Results at 10 Years of the RESOLVE Study (RESOLVE+10)

Results at 10 Years of the RESOLVE Study (REverse Metabolic SyndrOme by Lifestyle and Various Exercise)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04453098
Acronym
RESOLVE+10
Enrollment
150
Registered
2020-07-01
Start date
2020-09-30
Completion date
2021-07-31
Last updated
2020-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

physical activity, spa residential lifestyle program, prevention

Brief summary

10-year effect of a lifestyle intervention program (exercise, sedentary lifestyle and dietary diet) on abdominal visceral adipose tissue (primary endpoint of the RESOLVE study 10 years ago): influence of kinetics abdominal visceral adipose tissue loss in the first year of follow-up on abdominal visceral adipose tissue at 10 years

Detailed description

The RESOLVE + 10 protocol was design to provide a 10-year effect of a lifestyle intervention program (exercise, sedentary lifestyle and dietary diet) on abdominal visceral adipose tissue. In the present protocol, parameters are measured just once, during 3 hours, to compared the results with those of the protocol RESOLVE (5 measurement times over a year 10 years ago: before the thermal modification program of the lifestyle ( exercise, sedentary lifestyle and diet) of 3 weeks (D0), after the thermal program (D21), at the 3rd month (M3), 6th month (M6) and 12th month of follow-up (M12), to which was matched a healthy control group). Statistical analysis will be performed using Stata software (version 13; Stata-Corp, College Station, Tex., USA). All statistical tests will be two-sided and p inferior to 0.05 will be considered significant. Qualitative variables will be described in terms of numbers and proportions. Quantitative variables will be described in terms of numbers, mean standard deviation or median according to statistical distribution (normality studied using Shapiro-Wilk test). Graphic representations will be complete presentations of results. Comparisons between patients and controls, concerning loss of abdominal visceral adipose tissue at 10 years, will be performed using Student t-test or Mann-Whitney test if the assumptions of anova are not met (normality and homoscedasticity analyzed using Fisher-Snedecor test). The results will be expressed as effect-size and 95 percent confidence intervals. The primary analysis should be completed by multivariable analysis (linear regression with logarithmic transformation of dependent outcome if necessary) considering an adjustment on covariates fixed according to univariate results and clinical relevance. The results will be expressed as regression coefficients and 95percent confidence intervals. Furthermore, the abdominal visceral adipose tissue loss kinetics in the first year of follow-up will be considered an independent variable and treated as a functional variable. The intra-group comparisons (for patients and for controls) will be performed using paired statistical tests: paired t-test or Wilcoxon test. The results will be expressed as effect-size and 95 percent confidence intervals. Comparisons between independent groups will be done similarly as presented previously for other quantitative outcomes (body composition, quality of life, skin conductance, etc.). Multivariable analyses will be applied similarly as described previously. The comparisons concerning categorical variables will be realized using Chi-squared or when appropriate Fischer-exact test. The relations between quantitative outcomes will be analyzed using correlation coefficients (Pearson or Spearman according to statistical distribution). Considering the several multiple comparisons, a correction of the type I error will be applied (Sidak's correction).

Interventions

BEHAVIORAL3-week residential program based on a tryptic (diet,

3-week residential program based on a tryptic (diet, exercise, education). The three weeks intervention was followed by a 1-year at-home follow-up. In the original protocol, participants were involved in a 3-week residential program based on a tryptic (diet, exercise, education).

Sponsors

University Hospital CHU Clermont-Ferrand, 58 rue Montalembert 63003 Clermont-Ferrand, France
CollaboratorUNKNOWN
Université d'Auvergne
CollaboratorOTHER
LaPSCo laboratory, Physiological and Psychosocial Stress team, UMR CNRS 6024, Clermont-Ferrand, France
CollaboratorUNKNOWN
LaPEC laboratory (EA 4278), University of Avignon, Avignon, France
CollaboratorUNKNOWN
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

participants receive an intervention throughout the protocol

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* patients and healthy controls included in the RESOLVE study

Exclusion criteria

* refusal of participation

Design outcomes

Primary

MeasureTime frameDescription
Abdominal visceral adipose tissue loss, a primary cardiovascular risk (CVR) factor, highly related to morbidity and mortalityYear 10to assess the ability of a lifestyle program in decreasing abdominal visceral fat, one of the major health-related factor It will be assessed from dual-energy X-ray absorptiometry

Secondary

MeasureTime frameDescription
Waist circumferenceYear 10measured in centimeter
heart rateYear 10measured in battment per minutes
Evaluation of CCK levelYear 10Blood analyses on CCK
Evaluation of VEGF levelYear 10Blood analyses on VEGF
Evaluation of PAI1 levelYear 10Blood analyses on PAI1
insulin levelYear 10Blood analyses on insulin
HbA1c levelYear 10Blood analyses on HbA1c
blood glucose levelYear 10Blood analyses on blood glucose
albumin levelYear 10Blood analyses on blood albumin
transthyretin levelYear 10Blood analyses on transthyretin
HomeostasisYear 10Blood analyses on Homeostasis (Fibroblast growth factor 23)
OsteoresorptionYear 10Blood analyses on Osteoresorption (C-terminal Telopeptide of Type I collagen)
OsteoformationYear 10Blood analyses on Osteoformation (decarboxylated osteocalcine and BSAP)
Muscle massYear 10measured using Impedancemeter, Densitometry x-ray absorption, Peripheral quantitative computed tomography (pQCT) and Quantitative ultrasounds (QUS)
weightYear 10measured in kilogramms
systolic blood pressureYear 10measured in millimeter of mercure
fat massYear 10measured using Impedancemeter, Densitometry x-ray absorption, Peripheral quantitative computed tomography (pQCT) and Quantitative ultrasounds (QUS)
bone structureYear 10measured using Impedancemeter, Densitometry x-ray absorption, Peripheral quantitative computed tomography (pQCT) and Quantitative ultrasounds (QUS)
Epicardial adipose tissueYear 10measures of epicardial adipose tissue using Magnetic resonance imaging (MRI) and echocardiography
myocardial triglyceridesYear 10measures of myocardial triglycerides using MRI
cardiac remodeling and functionYear 10measures cardiac remodeling and function using MRI and echocardiography)
DepressionYear 10Assessing depression using Hospital anxiety and depression scale- HAD. It's a 14-item questionnaire about frequency of perception about anxious (HAD-A: 7 items) and depressive (HAD-D: 7 items) symptoms. Items are made of a 4-point scale frequency of symptoms, varying from never to always. Scores higher than 8 for HAD-A or HAD-D mean a possible symptomatology, and scores higher than 11 mean a clear and proper diagnostic of depressive or anxious disorder.
anxietyYear 10Assessing anxiety using State and trait anxiety inventory which consists of separate self-report scales measuring to distinct anxiety concepts: state anxiety and trait anxiety. Both state and trait anxiety are explored by a 20-item questionnaire made of a 4-point scale from never to always.
General healthYear 10Assessing general health using General Health Questionnaire with 36 items (SF-36)
StressYear 10Assessing stress using visual analog scale of 100 mm, ranging from very low (0) to very high (100).
FatigueYear 10Assessing fatigue using visual analog scale of 100 mm, ranging from very low (0) to very high (100).
SleepYear 10Assessing sleep using visual analog scale of 100 mm, ranging from very low (0) to very high (100).
Quantification of liver fibrosisYear 10Liver fibrosis by fibroscanner (liver stiffness) and fibrotest
Vo2maxYear 10Assessing factors regarding fitness are related to Vo2max (maximal exercise test)
BurnoutYear 10Assessing burnout using Maslach Burnout Inventory, composed of 22 items designed to assess the three components of the burn-out syndrome: emotional exhaustion (9 items), depersonalization (5 items) and reduced personal accomplishment (8 items). Items are made of a 7-point scale frequency of feelings, varying from never to every day. The scores for each component of the burn-out syndrome are considered separately and are not combined into a single total score. If desired for participant feedback, each score can be coded as low, average, or high.
MindfulnessYear 10Assessing mindfulness using Freiburg Mindfulness Inventory a consistent and reliable scale evaluating several important aspects of mindfulness. Mindfulness has been described as a non-elaborative, non-judgmental present-centred awareness in which each thought, feeling or sensation that arises in the attention field is acknowledged and accepted as it is. Mindfulness appears as an attribute of consciousness long believed to promote well-being. Each self-descriptive statement of the FMI is evaluated using a four-point Likert scale ranging from 1 (strongly disagree) to 4 (strongly agree)
Coping strategyYear 10Assessing coping using Brief COPE Questionnaire made to evaluate self-perceived reaction to a particular situation. The 28 items of the BCQ explore the 14 different theoretically identified coping responses (with two items for each of the measured coping strategies): self-distraction, active coping, denial, substance use, use of emotional support, use of instrumental support, Behavioral disengagement, venting, positive reframing, planning, humor, acceptance, religion, and self-blame. Items of BCQ are scored on a four-point Likert-type scale, ranging from 1 = strongly disagree to 4 = strongly agree.
EmotionsYear 10Assessing emotions using Emotion Regulation Questionnaire a 10-item scale designed to measure respondents' tendency to regulate their emotions in two ways: 1) cognitive reappraisal and 2) expressive suppression. Respondents answer each item on a 7-point
FitnessYear 10Assessing factors regarding fitness are related to 6-minutes walking test.
strengthYear 10Assessing factors regarding fitness are related to strength
leptin variationYear 10Blood analyses on leptin
ghrelin variationYear 10Blood analyses on ghrelin
NPY variationYear 10Blood analyses on NPY
adiponectin variationYear 10Blood analyses on adiponectin
Perception of workYear 10Assessing perception of work using Job Content Questionnaire of Karasek which assessed job demands, job control and social support through 26 items. The questionnaire measures 9 items of job demands, 9 items of job control and 8 items of social support. Items are scored on a four-point Likert-type scale, ranging from 1 = strongly disagree to 4 = strongly agree. Among the 26 items, 5 negative statements require reverse scoring. From French data, the job strain threshold is set for a demands score higher than 20 and a control score lower than 71; the isostrain threshold is determined from a combining score of job strain and social support lower than 24. We would ask the participants to fulfil the questionnaire from memories that they keep of their work.
Self-efficacyYear 10Assessing self-efficacy using Perceived self-efficacy scale created to assess a general sense of perceived self-efficacy with the aim in mind to predict coping with daily hassles as well as adaptation after experiencing all kinds of stressful life events. Responses are made on a 4-point scale for the 10 items (from false to true). The final composite score (ranged from 10 to 40) is obtained by summing up the responses to all 10 items. An example of item is I am confident that I could deal efficiently with unexpected events.
AddictionYear 10Assessing addiction to work using Work Addiction Risk test (WART). The WART is a self-administered test with 25 statements for which the answers are scored 1-never true to 4-always true \[20,26\]. Respondents read the statements and mark their answers to describe their work habits \[19,27\]. The total score is the sum of the responses to the items-25 to 100-and the higher the score, the more one is considered addicted to work \[18,21\]. Scores from 25 to 56 were defined as at low-risk of work addiction; 57 to 66 as at medium-risk of work addiction, and from 67 to 100 as at high-risk of work addiction.
AlexithymiaYear 10Assessing alexithymia using Toronto Alexithymia Scale For this scale, a three-factor structure was proposed: difficulty identifying feelings, difficulty describing feelings and externally oriented thinking. Responses are made on a 5-point scale from strongly agree to strongly disagree.
Illness perceptionYear 10Assessing illness perception using Brief Illness Perception Questionnaire (B-IPQ), adapted for stress at work). It's a self-questionnaire comprising an 11-point scale, including 8 items measuring cognitive and emotional illness perceptions (consequences, timeline, personal control, treatment control, symptoms, coherence, illness concern and negative emotions). The total score is calculated by averaging all items (after reversed some items). A high score meant that diabetes was perceived as a threat.
MetacognitionYear 10Assessing metacognition using MetaCognition Questionnaire. It is a 30-item questionnaire made of 5-point scales. The MCQ-30 is structured in five factors: cognitive confidence, positive beliefs about worry, cognitive self-consciousness, negative beliefs about uncontrollability of thoughts and danger, and beliefs about need to control thoughts.
Time perceptionYear 10Assessing time perception using Zimbardo Time Perspective Inventory, a self-reported questionnaire comprising 56 items. Responses are made on a 5-point scale from very uncharacteristic to very characteristic. It explores 3 temporalities and 5 dimensions.
Life styleYear 10Assessing factors regarding lifestyle are related to smoking, alcohol, coffee, food intake (questionnaires), and physical activity (Recent Physical Activity Questionnaire)
Treatment perceptionYear 10Assessing factors regarding psychology and treatment are related to perception of treatment (Beliefs about Medicines Questionnaire), adherence to treatment (Visual analog scales from never to always), barriers to treatment (QUILAM) and treatment satisfaction (treatment SATisfaction with MEDicines Questionnaire).
questionnaires used 10 years agoYear 10Understanding and knowledge about the metabolic syndrome (4 items), comparative optimism (4 items), motivation to eat healthy (16 items) and motivation to practise physical activity (16 items).
CholesterolYear 10Blood analyses on HDLc and LDL-cholesterol
HbA1cYear 10Blood analyses on HbA1c
Triglycerides (TG)Year 10Blood analyses on Triglycerides (TG)
CortisolYear 10Blood analyses on Cortisol
DHEASYear 10Blood analyses on DHEAS
LeptinYear 10Blood analyses on Leptin
BDnFYear 10Blood analyses on BDnF
CytokinesYear 10Blood analyses on Pro-inflammatory Cytokines: IL-1β, IL-6, IL-1, TNFα, NPY
Telomeres lengthYear 10Blood analyses on Telomeres length
Genetic polymorphisms related to stressYear 10Polymorphism of the angiotensin converting enzyme and Polymorphism of the serotonin are measured by Blood cells
diastolic blood pressureYear 10measured in millimeter of mercure
blood flow velocityYear 10Assessing on blood flow velocity by laser speckle contrast imaging (LSCI) and microvascular perfusion by laser-doppler flowmetry (LDF), flowmotion and Iontophoresis procedure.
microvascular perfusionYear 10Assessing microvascular perfusion by laser-doppler flowmetry (LDF).
flowmotionYear 10Assessing flowmotion
iontophoresisYear 10Assessing iontophoresis procedure
heart rate variabilityYear 10Assessing heart rate variability by Holter
skin conductanceYear 10Assessing skin conductance by Wristband electrodes - Empatica 4.
Quantification of liver steatosis and fibrosisYear 10Liver steatosis by MRI, fibroscanner (ultrasonic attenuation) and Aixplorer (Lipersonic Imagine®).
carotid intima-media thicknessYear 10Assessing on carotid intima-media thickness by high-resolution B-mode ultrasound.

Countries

France

Contacts

Primary ContactLise LACLAUTRE
promo_interne_drci@chu-clermontferrand.fr+33473754963

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026